Actos Lawsuits and the Bellwether Trial

If you have developed bladder cancer after taking Actos, you may be interested in filing an Actos lawsuit. This diabetes medication is one of the most popular prescriptions in the world, with sales of more than $3 billion in 2009. Unfortunately, it is now known to cause bladder cancer. If you have developed bladder cancer while taking Actos, you may wish to consider filing an Actos lawsuit to receive financial compensation. This article will discuss the Actos lawsuit process, as well as the Bellwether trial.

Actos lawsuits

Actos was a well-known drug, which brought Takeda Pharmaceuticals a record amount of money. Sales topped $24 billion between 1999 and 2014. Unfortunately, patients who were taking the medication developed bladder cancer and accrued significant medical bills. Actos lawsuits seek to recover these costs, as well as lost wages, and punish Takeda for withholding important information from patients. These lawsuits were also filed under multidistrict litigation (MDL) No. 2299.

Initially, lawsuits filed against Takeda were filed in separate state courts. As a result, multidistrict litigation (MDL) was created to handle the hundreds of thousands of Actos lawsuits filed against the pharmaceutical company. MDLs combine federal suits to reduce the number of duplicated cases, speed up the legal process, and ensure that all parties receive the best representation possible. While the results of multidistrict litigation are not final, a favorable verdict could serve as a precedent for other lawsuits filed against Takeda.

Side effects

When used together with other medications, Actos can cause low blood sugar. Be sure to talk to your healthcare provider if you notice any of these symptoms. You should also report any dark urine or yellow skin and eyes to your healthcare provider. If you are already taking another medication, talk to your doctor about any possible changes to the dose. Your provider may need to adjust your dosage if you take Actos with another drug.

Some people experience a rise in blood sugar when they stop taking Actos abruptly. In rare cases, users may develop health issues linked to type 2 diabetes. Other complications may occur, such as problems with the kidneys and eyes. If you are on Actos for an extended period, you should discuss any symptoms with your physician. Some of these side effects may be minor, while others may be severe and require immediate medical attention. If you are considering stopping Actos, keep a record of your symptoms and discuss them with your doctor.


A former employee of Takeda Pharmaceuticals has filed a compensation for Actos lawsuit, alleging that the company concealed information about the dangers of Actos from the FDA. The former employee was a safety consultant and claimed that Takeda knew about the cancer-causing potential of the Actos drug but chose to hide the information. The case was eventually dismissed due to a judge’s order, but not before many patients joined the multidistrict litigation (MDL) against the drugmaker. In addition to the settlement, the former employee is seeking damages for pain, suffering, and loss of consortium.

The compensation for Actos lawsuit can be filed by patients who developed cancer from the drug, or the families of those who died from the effects of the drug. The FDA’s warning about Actos’s link to bladder cancer resulted in a deal between Takeda and the drugmakers, which led to billions of dollars in compensation for Actos victims. In addition to bladder cancer, Actos has also been linked to anemia, bone fractures, and congestive heart failure.

Bellwether trial

In the Actos lawsuit, the jury heard from Dr. Jeffrey Greenberg, who was once a drug researcher at Bristol-Myers Squibb Company and Johnson & Johnson’s Janssen Pharmaceuticals unit. Greenberg reviewed internal Takeda documents. He explained how the company had to obtain certain types of data to prove Actos’ safety. The jury rejected Takeda’s claim that the drug was not linked to bladder cancer.

In other words, this trial will be the stepping stone for future Actos litigation. The judge will preside over pretrial discovery and motions for the case. Many bellwether trials are the catalysts for settlement negotiations. This Actos lawsuit trial is scheduled to begin on January 27 in the U.S. District Court for the Western District of Louisiana. Actos lawsuits are filed in federal multidistrict litigation (MDL) in the Western District of Louisiana.


As a diabetes drug, Actos is one of the most popular on the market. However, it’s not without controversy. The drug makers, Eli Lilly, and Takeda Pharmaceuticals were known to cause bladder cancer but kept this information secret. Consequently, they failed to warn the public about the serious risks associated with the drug. As a result, there are now Actos lawsuits filed against the drug makers for the serious diseases that they have caused.

Some of the Actos lawsuits have accused Takeda Pharmaceuticals of failing to warn patients of its risks. Nonetheless, the pharmaceutical company settled nearly 9,000 claims for $2.4 billion in 2015. The firm has been defending the drug’s safety and effectiveness. Although the Actos lawsuit litigation has been largely inactive since Takeda settled the cases, it remains an option for those affected by the side effects of the drug.

Leave a Reply

Your email address will not be published. Required fields are marked *